The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention

Drug-eluting stents (DES) were inserted in 180 patients (270 stents), mean age 63 years, and bare-metal stents (BMS) were inserted in 191 patients (301 stents), mean age 63 years, during percutaneous coronary intervention. Baseline characteristics were similar for patients treated with DES or BMS. T...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of therapeutics Vol. 14; no. 3; p. 277
Main Authors Dilmanian, Hajir, Aronow, Wilbert S, Mundia, Mubasir, Pucillo, Anthony L, Weiss, Melvin B, Kalapatapu, Kumar, Monsen, Craig E
Format Journal Article
LanguageEnglish
Published United States 01.05.2007
Subjects
Angioplasty, Balloon, Coronary
Coronary Restenosis - prevention & control
Drug Delivery Systems
Equipment Design
Female
Humans
Male
Middle Aged
Stents - adverse effects
Stents - statistics & numerical data
Thrombosis - etiology
Online AccessGet more information

Cover

More Information
Summary:Drug-eluting stents (DES) were inserted in 180 patients (270 stents), mean age 63 years, and bare-metal stents (BMS) were inserted in 191 patients (301 stents), mean age 63 years, during percutaneous coronary intervention. Baseline characteristics were similar for patients treated with DES or BMS. The average stent length was longer for DES (16.83 mm) versus BMS (15.45 mm) (P = 0.0026). The average stent diameter was shorter for DES (2.89 mm) versus BMS (3.00 mm) (P = 0.00027). In-hospital stent thrombosis occurred in one of 270 DES (0.4%) versus three3 of 301 BMS (1.0%) (P = not significant).
ISSN:1075-2765
DOI:10.1097/MJT.0b013e3180653377